Global Home Infusion Therapy Market by Application (Chemotherapy, Anti-infective), by Product (Needleless Connectors, Infusion Pumps) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global home infusion therapy market was worth USD 18.3 billion in 2020. It is projected to grow at an 8.5% compound annual growth rate (CAGR), between 2021 and 2028. Infusion therapy is the treatment of patients at home using needles or catheters to administer drugs or biological products. Patients prefer to receive treatment at home over hospitals and healthcare facilities because it is more cost-effective and convenient. This further drives the demand for home infusion therapy. Market drivers include a growing geriatric population, declining mobility, increasing preference for home care and technological advances. Infusion therapy is required for many conditions, including congestive heart disease, cancer, and immune deficiencies. These conditions are not treatable with oral medications. These patients need long-term care, so home infusion therapy can be a cost-effective option to hospital treatment.
Infusion therapy is another benefit that provides nutrition to patients. These devices are a result of technological advances that make home infusion therapy easier and more user-friendly. Smart pumps are becoming more popular because they have advanced features. These pumps are particularly useful for chemotherapy patients as they allow for precise and controlled infusion rates.
The fastest-growing segment in the forecast period is chemotherapy based on its application. The WHO estimates that there were 19.3 million cases of cancer worldwide in 2020. It is expected that the high incidence of cancer will positively impact the growth and future prospects of the chemotherapy market. The market will be driven by the rising popularity of home-based treatment for cancer, due to its cost-effectiveness and other benefits.
COVID19 impact: 14.0% increase in demand
|
Pandemic Impact |
Outlook after COVID |
|
Emergency room visits fell by half during the pandemic. Admissions not directly related to COVID-19 also experienced a similar, or even faster decline. |
Covid-19 discovered the value and effectiveness of home and in-house treatment for conditions like diabetes and cancer. |
|
The pandemic resulted in lower rates of hospitalizations and emergency room utilization, which has led to a demand for home medicine delivery. |
Cancer Care at Home has added 12 chemotherapeutics to the program, which were previously not available through home infusion. The program has referred 301 patients to home infusion out of 670 patients. This represents a 46% increase over the previous in-house treatment for cancer. |
|
Smiths Medical reported that the demand for infusion pumps has increased significantly. Due to COVID-19-related demand, Smiths Medical saw an increase in revenue from its infusion systems of 4%. |
FDA released April 2020 guidelines for infusion pumps and their accessories. It stated that it would not object to certain modifications being made by companies to infusion pumps already cleared. This has had a positive effect on the overall market. |
Many people were hospitalized due to the COVID-19 pandemic. Many of them had to be put on ventilators. As infected patients were to be placed in areas that will not infect other patients or healthcare professionals, this occupied hospital space. Companies are looking to move patients from hospitals to their homes, increasing demand for home-infusion therapy. The Penn Center for Cancer Care Innovation at University of Pennsylvania's Abramson Cancer Center launched the Cancer Care at Home program in February 2020. The program was designed to improve the availability of oncology treatment to patients at home. The company reported an increase of 700% in patients who participated in the program from mid-March through late-April. This shows the bright future for home infusion markets in the coming years.
Product Insights
Infusion pumps accounted for 50.5% of the market share in 2020. These pumps are popular for administering nutrients and medication. Segment growth is further supported by the availability of many products such as an intravenous, syringe and multichannel pump, as well as peristaltic pumps. The segment growth is expected to be aided by the rising demand for ambulatory pumps and syringes, which are a result of increasing home healthcare preference. The market can be divided into intravenous sets and IV cannulas as well as needleless connectors.
Smart pumps are becoming more popular because they have advanced features such as barcode technology. This technology helps to verify a patient's identity as well as prevents drug administration errors. The highest expected CAGR for needleless connectors is in the forecast period. These connectors provide better safety and facilitate smooth surgeries. They also adhere to good clinical practice (GCP), which is a key contributor to the segment's growth.
Application Insights
With a 27.1% share, the anti-infective segment dominated home infusion therapy's market in 2020. This is due to the large number of procedures that are required for the administration and monitoring of antibiotics. This helps to reduce the risk of infection in patients with other hospital acquired infections (HAIs). The market can be divided into several segments based on its application: anti-infective and endocrinology; hydration therapy; chemotherapy; enteral nutrition; parenteral nutrition; specialty pharmaceuticals, among others.
The fastest-growing segment in the forecast period is expected to be chemotherapy. The demand for pressure pumps will increase due to the increasing incidence of cancer. The pumps used for home chemotherapy are small, continuous pressure pumps that don't require batteries and can be used for longer periods of time. These pumps allow chemotherapy drugs to be administered at the correct infusion speed and the right amount.
Regional Insights
North America was the dominant market for home infusion therapy, with a share at 57.1% in 2020. This trend will continue through the forecast period. This is due to the increasing R&D in this region and the growing adoption of new technology for infusion pumps. This market is driven by the growing demand for long-term treatment for certain patients. This market will grow due to the development of alternative healthcare settings and home-infusion services, as well as shifting preference from acute to home care settings.
Over the forecast period, the Asia Pacific market will grow at a substantial CAGR of 10.4%. This is due to increasing awareness among patients about the advantages of home infusion therapy over other in-hospital procedures, and the rising prevalence of diabetes in this region.
Market Share Insights & Key Companies
Global markets are highly competitive. The rapid adoption of modern healthcare technology to improve healthcare services is one of the main factors that drives market competitiveness. Major players also often resort to mergers, acquisitions and product launches in order to maintain market share and diversify product lines. B. Braun, for example, launched Easypump, a home-infusion therapy app that is available to both healthcare professionals and patients. The app provides instructions for how to use and manage the pump, which helps patients safely administer medication. The following are some of the most prominent players in global home infusion therapy:
-
CVS/Coram
-
Option Care Health
-
BriovaRx/Diplomat
-
PharMerica
-
Fresenius Kabi
-
ICU Medical, Inc.
-
B. Braun Melsungen AG
-
Baxter
-
BD
-
Caesarea Medical Electronics
-
Smiths Medical
-
Terumo Corporation
-
JMS Co. Ltd.
Up Market Research published a new report titled “Home Infusion Therapy Market research report which is segmented by Application (Chemotherapy, Anti-infective), by Product (Needleless Connectors, Infusion Pumps), By Players/Companies Fresenius Kabi, PharMerica, Smiths Medical, B Braun Melsungen AG, Option Care Health, Caesarea Medical Electronics, BriovaRx/Diplomat (UnitedHealth Optum), CVS/Coram, Baxter, BD, ICU Medical Inc, Terumo Corporation, JMS Co Ltd”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Home Infusion Therapy Market Research Report |
| By Application | Chemotherapy, Anti-infective |
| By Product | Needleless Connectors, Infusion Pumps |
| By Companies | Fresenius Kabi, PharMerica, Smiths Medical, B Braun Melsungen AG, Option Care Health, Caesarea Medical Electronics, BriovaRx/Diplomat (UnitedHealth Optum), CVS/Coram, Baxter, BD, ICU Medical Inc, Terumo Corporation, JMS Co Ltd |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 200 |
| Number of Tables & Figures | 140 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Home Infusion Therapy Market Report Segments:
The market is segmented by Application (Chemotherapy, Anti-infective), by Product (Needleless Connectors, Infusion Pumps).
Home Infusion Therapy Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Home Infusion Therapy Market
Overview of the regional outlook of the Home Infusion Therapy Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Home Infusion Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Home Infusion Therapy Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Chemotherapy
2. Anti-infective
7. By Product:1. Needleless Connectors
2. Infusion Pumps
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Home Infusion Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Home Infusion Therapy Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Home Infusion Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Home Infusion Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Home Infusion Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Home Infusion Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Home Infusion Therapy Market Size & Forecast, 2018-2028
4.5.1 Home Infusion Therapy Market Size and Y-o-Y Growth
4.5.2 Home Infusion Therapy Market Absolute $ Opportunity
Chapter 5 Global Home Infusion Therapy Market Analysis and Forecast by Application
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Application
5.1.2 Basis Point Share (BPS) Analysis by Application
5.1.3 Absolute $ Opportunity Assessment by Application
5.2 Home Infusion Therapy Market Size Forecast by Application
5.2.1 Chemotherapy
5.2.2 Anti-infective
5.3 Market Attractiveness Analysis by Application
Chapter 6 Global Home Infusion Therapy Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Home Infusion Therapy Market Size Forecast by Product
6.2.1 Needleless Connectors
6.2.2 Infusion Pumps
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Home Infusion Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Home Infusion Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Home Infusion Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Home Infusion Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Home Infusion Therapy Market Size Forecast by Application
9.6.1 Chemotherapy
9.6.2 Anti-infective
9.7 Basis Point Share (BPS) Analysis by Application
9.8 Absolute $ Opportunity Assessment by Application
9.9 Market Attractiveness Analysis by Application
9.10 North America Home Infusion Therapy Market Size Forecast by Product
9.10.1 Needleless Connectors
9.10.2 Infusion Pumps
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Home Infusion Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Home Infusion Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Home Infusion Therapy Market Size Forecast by Application
10.6.1 Chemotherapy
10.6.2 Anti-infective
10.7 Basis Point Share (BPS) Analysis by Application
10.8 Absolute $ Opportunity Assessment by Application
10.9 Market Attractiveness Analysis by Application
10.10 Europe Home Infusion Therapy Market Size Forecast by Product
10.10.1 Needleless Connectors
10.10.2 Infusion Pumps
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Home Infusion Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Home Infusion Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Home Infusion Therapy Market Size Forecast by Application
11.6.1 Chemotherapy
11.6.2 Anti-infective
11.7 Basis Point Share (BPS) Analysis by Application
11.8 Absolute $ Opportunity Assessment by Application
11.9 Market Attractiveness Analysis by Application
11.10 Asia Pacific Home Infusion Therapy Market Size Forecast by Product
11.10.1 Needleless Connectors
11.10.2 Infusion Pumps
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Home Infusion Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Home Infusion Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Home Infusion Therapy Market Size Forecast by Application
12.6.1 Chemotherapy
12.6.2 Anti-infective
12.7 Basis Point Share (BPS) Analysis by Application
12.8 Absolute $ Opportunity Assessment by Application
12.9 Market Attractiveness Analysis by Application
12.10 Latin America Home Infusion Therapy Market Size Forecast by Product
12.10.1 Needleless Connectors
12.10.2 Infusion Pumps
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Home Infusion Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Home Infusion Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Home Infusion Therapy Market Size Forecast by Application
13.6.1 Chemotherapy
13.6.2 Anti-infective
13.7 Basis Point Share (BPS) Analysis by Application
13.8 Absolute $ Opportunity Assessment by Application
13.9 Market Attractiveness Analysis by Application
13.10 Middle East & Africa (MEA) Home Infusion Therapy Market Size Forecast by Product
13.10.1 Needleless Connectors
13.10.2 Infusion Pumps
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Home Infusion Therapy Market: Competitive Dashboard
14.2 Global Home Infusion Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Kabi
14.3.2 PharMerica
14.3.3 Smiths Medical
14.3.4 B Braun Melsungen AG
14.3.5 Option Care Health
14.3.6 Caesarea Medical Electronics
14.3.7 BriovaRx/Diplomat (UnitedHealth Optum)
14.3.8 CVS/Coram
14.3.9 Baxter
14.3.10 BD
14.3.11 ICU Medical Inc
14.3.12 Terumo Corporation
14.3.13 JMS Co Ltd
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Home Infusion Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Home Infusion Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Home Infusion Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Home Infusion Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Home Infusion Therapy Market Size & Forecast, 2018-2028
4.5.1 Home Infusion Therapy Market Size and Y-o-Y Growth
4.5.2 Home Infusion Therapy Market Absolute $ Opportunity
Chapter 5 Global Home Infusion Therapy Market Analysis and Forecast by Application
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Application
5.1.2 Basis Point Share (BPS) Analysis by Application
5.1.3 Absolute $ Opportunity Assessment by Application
5.2 Home Infusion Therapy Market Size Forecast by Application
5.2.1 Chemotherapy
5.2.2 Anti-infective
5.3 Market Attractiveness Analysis by Application
Chapter 6 Global Home Infusion Therapy Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Home Infusion Therapy Market Size Forecast by Product
6.2.1 Needleless Connectors
6.2.2 Infusion Pumps
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Home Infusion Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Home Infusion Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Home Infusion Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Home Infusion Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Home Infusion Therapy Market Size Forecast by Application
9.6.1 Chemotherapy
9.6.2 Anti-infective
9.7 Basis Point Share (BPS) Analysis by Application
9.8 Absolute $ Opportunity Assessment by Application
9.9 Market Attractiveness Analysis by Application
9.10 North America Home Infusion Therapy Market Size Forecast by Product
9.10.1 Needleless Connectors
9.10.2 Infusion Pumps
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Home Infusion Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Home Infusion Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Home Infusion Therapy Market Size Forecast by Application
10.6.1 Chemotherapy
10.6.2 Anti-infective
10.7 Basis Point Share (BPS) Analysis by Application
10.8 Absolute $ Opportunity Assessment by Application
10.9 Market Attractiveness Analysis by Application
10.10 Europe Home Infusion Therapy Market Size Forecast by Product
10.10.1 Needleless Connectors
10.10.2 Infusion Pumps
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Home Infusion Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Home Infusion Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Home Infusion Therapy Market Size Forecast by Application
11.6.1 Chemotherapy
11.6.2 Anti-infective
11.7 Basis Point Share (BPS) Analysis by Application
11.8 Absolute $ Opportunity Assessment by Application
11.9 Market Attractiveness Analysis by Application
11.10 Asia Pacific Home Infusion Therapy Market Size Forecast by Product
11.10.1 Needleless Connectors
11.10.2 Infusion Pumps
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Home Infusion Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Home Infusion Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Home Infusion Therapy Market Size Forecast by Application
12.6.1 Chemotherapy
12.6.2 Anti-infective
12.7 Basis Point Share (BPS) Analysis by Application
12.8 Absolute $ Opportunity Assessment by Application
12.9 Market Attractiveness Analysis by Application
12.10 Latin America Home Infusion Therapy Market Size Forecast by Product
12.10.1 Needleless Connectors
12.10.2 Infusion Pumps
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Home Infusion Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Home Infusion Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Home Infusion Therapy Market Size Forecast by Application
13.6.1 Chemotherapy
13.6.2 Anti-infective
13.7 Basis Point Share (BPS) Analysis by Application
13.8 Absolute $ Opportunity Assessment by Application
13.9 Market Attractiveness Analysis by Application
13.10 Middle East & Africa (MEA) Home Infusion Therapy Market Size Forecast by Product
13.10.1 Needleless Connectors
13.10.2 Infusion Pumps
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Home Infusion Therapy Market: Competitive Dashboard
14.2 Global Home Infusion Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Kabi
14.3.2 PharMerica
14.3.3 Smiths Medical
14.3.4 B Braun Melsungen AG
14.3.5 Option Care Health
14.3.6 Caesarea Medical Electronics
14.3.7 BriovaRx/Diplomat (UnitedHealth Optum)
14.3.8 CVS/Coram
14.3.9 Baxter
14.3.10 BD
14.3.11 ICU Medical Inc
14.3.12 Terumo Corporation
14.3.13 JMS Co Ltd
Segments Covered in the Report
The global Home Infusion Therapy market has been segmented based on
By Application
The global Home Infusion Therapy market has been segmented based on
By Application
- Chemotherapy
- Anti-infective
- Needleless Connectors
- Infusion Pumps
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Fresenius Kabi
- PharMerica
- Smiths Medical
- B Braun Melsungen AG
- Option Care Health
- Caesarea Medical Electronics
- BriovaRx/Diplomat (UnitedHealth Optum)
- CVS/Coram
- Baxter
- BD
- ICU Medical Inc
- Terumo Corporation
- JMS Co Ltd
Our Clients
Related Reports
Some other reports from this category!
